Overview
The Endo One dual-wavelength diode laser offers a precise and effective solution for this emerging demand. The combined action of its two wavelengths allows providers to treat both adipose tissue and dermal laxity within a single session:
- 980 nm wavelength effectively reduces localized fat pockets (abdomen, flanks, arms, inner thighs, knees).
- 1470 nm wavelength contracts collagen fibers and stimulates long-term neocollagenesis, improving tissue firmness and skin elasticity.
This dual mechanism is particularly relevant for patients with the so-called “Ozempic body”, where the skin appears like an “empty bag” after rapid volume loss. Traditional technologies often fail in these cases because they either remove fat without tightening or tighten superficially without addressing adipose tissue. Endo One bridges this gap, producing more balanced and natural outcomes.
From a provider’s perspective, Endo One adds value in several ways:
- Expands treatment offerings to a growing patient segment (post-weight-loss and post-bariatric).
- Provides a minimally invasive alternative to excisional surgery, appealing to patients not ready for operative interventions.
- Generates high patient satisfaction and strong word-of-mouth, due to visible improvements with limited downtime.
Integrating Endo One into clinical practice enables providers to position themselves at the forefront of modern body contouring, delivering treatments that respond directly to new aesthetic demands in the post-weight-loss population.
Key Takeaways for Providers
- Addresses a New Patient Category: Ideal for “Ozempic body” cases where rapid weight loss leaves redundant skin with small fat deposits.
- Comprehensive Tissue Effect: 980 nm targets localized adipose tissue, while 1470 nm contracts and remodels collagen for lasting firmness.
- Differentiation & ROI: Offers a minimally invasive alternative to excisional surgery, positioning your clinic as a leader in advanced body contouring while generating premium treatment revenue.